STAT Plus: FTC loses its bid to block Novant’s hospital merger in North Carolina
antitrust
Antitrust laws are designed to protect competition and prevent monopolies. In the health care industry, antitrust laws can be used to challenge mergers and acquisitions that could reduce competition and lead to higher prices. However, antitrust cases can be complex and expensive, and it is often difficult to prove that a company has violated antitrust laws.
Articles on this page concern hospital consolidation, pharma mergers, and drug pricing as it relates to the availability of cheaper, generic versions.
Latest
STAT Plus: Here’s another sign the Biden administration is taking a harsher stance on hospital consolidation
STAT Plus: Republicans are using the FTC’s Lina Khan as an excuse for opposing drug pricing bills
STAT Plus: Klobuchar, Porter call for FTC to investigate price hikes by Janssen, Bristol Myers Squibb
STAT Plus: Lawmakers ask FTC to scrutinize pharma mergers over antitrust concerns
STAT Plus: Pharmalittle: Opioid settlements may yield tax breaks for drug makers; EMA probes heartburn meds for carcinogens
STAT Plus: Consumer groups and unions urge FTC to block AbbVie and Allergan merger
STAT Plus: Generic drug price-fixing suit is akin to earlier case, but ‘on steroids,’ Conn. prosecutor says
All Coverage
advertisement
